EFRIS URA Commodity Codes

Integumentary system and skin and mucous membranes and subcutaneous tissues, percutaneous approach

85813500 Category

Integumentary system and skin and mucous membranes and subcutaneous tissues, percutaneous approach is an EFRIS commodity class (code 85813500) under Administrative interventions or procedures, physiological systems and anatomical regions, introduction and irrigation and circulatory in Uganda Revenue Authority's e-invoicing system.

17 items in this category

  • 85813504Introduction of analgesics, hypnotics, sedatives into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813513Introduction of anti-infective envelope into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813512Introduction of anti-inflammatory into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813503Introduction of destructive agent into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813509Introduction of electrolytic and water balance substance into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813502Introduction of insulin into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813508Introduction of local anesthetic into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813516Introduction of monoclonal antibody into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813510Introduction of nutritional substance into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813514Introduction of other anti-infective into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813517Introduction of other antineoplastic into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813505Introduction of other diagnostic substance into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813501Introduction of other hormone into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813507Introduction of other therapeutic substance into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813515Introduction of oxazolidinones into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813506Introduction of radioactive substance into subcutaneous tissue, percutaneous approach
    Exempt
  • 85813511Introduction of serum, toxoid and vaccine into subcutaneous tissue, percutaneous approach
    Exempt